期刊文献+

采用“药品利用评估”标准促进比阿培南的合理应用

Promote the Rational Use of Biapenem with DUE
下载PDF
导出
摘要 采用回顾性调查方法,用2013年底修改后的比阿培南的DUE标准,对我院2014年1月~6月共175例比阿培南的使用情况进行分析评价。结果表明比阿培南DUE标准的修订,可以更好地促进比阿培南的临床合理应用。 Retrospective drug use evaluation (DUE) was applied on medicinal records from January to June 2013, and some modified countermeasures were put forward. The modified DUE was applied from January to June 2014 on 175 records from patients who took the drug therapy of biapenem. Through continuous improvement, the results of some indicators were improved, but there were still places to be improved.
出处 《药学与临床研究》 2015年第5期487-489,493,共4页 Pharmaceutical and Clinical Research
基金 苏州市2012年度科技发展计划(应用基础研究-医疗卫生)项目(SYSD2012135)三
关键词 比阿培南 药物利用评价 合理应用 Biapenem Drug use evaluation Rational use of drugs
  • 相关文献

参考文献5

二级参考文献19

  • 1Abdulbari Bener,Mohammad T Yousafzai,Abdulla OAA Al-Hamaq,Abdul-Ghani Mohammad,Ralph A DeFronzo.Parental transmission of type 2 diabetes mellitus in a highly endogamous population[J].World Journal of Diabetes,2013,4(2):40-46. 被引量:28
  • 2石庆平,孙利华,丁永为.采用DUR和DUE方法评价本医院恶性淋巴瘤患者的用药情况[J].中国药房,2006,17(21):1630-1632. 被引量:26
  • 3Petersen P J, Jaeobus N V, Weiss W J, et al. In vitro and in vivo activities of LJC10, 627, a new carbapenem with stability to dehydropeptidase Ⅰ [J]. Antimicrob Agents Chemother, 1991,35(1) : 203-207.
  • 4Malanoski G J, Collins L, Wennersten C, et al. In vitro activity of biapenem against clinical isolates of Gram-positive and Gram-negative bacteria [J]. Antimicrob Agents Chemother,1993,37(9) :2009-2016.
  • 5Koeppe P, Hoeffler D, Fitzen B. Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function [J]. Arzneimittel-Forschung, 1997,47(11):1250-1256.
  • 6Kozawa O, Uematsu T, Matsuno H, et al. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects [J]. Antimicrob Agents Chemother , 1998,42(6) : 1433-1436.
  • 7赵香兰.临床药代动力学[M].郑州:郑州大学出版社,2003年:113-187.
  • 8Nagashima S, Kozawa O, Otsuka T, et al. Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis [J]. J Antimicrob Chemother , 2000,46 (5) :839-842.
  • 9Nakashima M, Uematsu T, Ueno K, et al. Phase Ⅰ study of L-627, biapenem, a new parenteral earbapenem antibiotic [J]. Int J Clin Pharmacol Ther Toxicol,1993,31(2): 70-76.
  • 10Al-Niemat SI, Bloukh DT, Al-Harasis MD, et al.Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators [J].Saudi Med J, 2008,29 (5) : 743.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部